CFAI
C.F.A.I.
Government Data Intelligence Services

MERIDIAN BIOSCIENCE INC.

Company OH
Found in 2 federal databases · 14 total records
EPA (Environmental Protection Agency) 1 records
EPA TRI: MERIDIAN BIOSCIENCE INC.
TRI facility in CINCINNATI, OH (HAMILTON County)
View Source
fda 13 records
FDA Device Recall: Revogene C. difficile, in vitro diagnostic assay intended for use with the Revog 2026-01-14
Class II — The affected lots show a decline in performance over time, which may lead to false-negative results.
View Source
FDA Device Recall: Meridian Bioscience, alethia c. Difficile, Catalog Number 480050, Nucleic Acid 2025-11-26
Class II — The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.
View Source
FDA Device Recall: Meridian Bioscience, Group B Streptococcus, Catalog Number 480050, Nucleic Acid 2025-11-26
Class II — The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.
View Source
FDA Device Recall: Cardinal Health Clean Stool Transportation System-For the collection, transporta 2023-12-20
Class II — Due to a manufacturing defect, certain Para-Pak vials may be at risk for leakage.
View Source
FDA Device Recall: Para-Pak Zn-PVA/10% Formalin-for the routine collection, transportation, preserv 2023-12-20
Class II — Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to biological hazards associated with direct contact with the...
View Source
FDA Device Recall: Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative dete 2023-02-01
Class II — Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2
View Source
FDA Recall: Meridian Bioscience Inc — Class II 20220406
The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-posi | Product: Revogene, For In Vitro Diagnostic use ...
View Source
FDA Device Recall: Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clin 2022-04-06
Class II — The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-positive or indeterminate results.
View Source
FDA Device Recall: Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transc 2021-05-19
Class II — Emergency Use Application (EUA) application withdrawn as false negative results reported
View Source
FDA Device Recall: The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in se 2021-03-31
Class II — Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause ...
View Source
FDA Device Recall: PREMIER Cryptococcal Antigen, Catalog Number 602096 Product Usage: The PREMI 2019-01-23
Class II — An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false negative results when tested with patient specime...
View Source
FDA Device Recall: PREMIER EHEC and PREMIER EHEC Bulk. 2017-01-25
Class II — Internal testing has demonstrated that the indicated kit lots produce false positive results when tested with some broth specimens.
View Source
FDA Device Recall: illumipro-10 Incubator/Reader, Meridian Bioscience, Inc. The illumipro-10 inc 2014-07-09
Class II — Illumipro-10 instruments may have Block B chambers operating at an incorrect temperature as a result of incorrect temperature calibration.
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.